Condition: Urologic Neoplasms · Urogenital Neoplasms · Male Urogenital Diseases · Sponsor: The Netherlands Cancer Institute
This is a single-armed, single-centre, non-blinded phase II trial to assess efficacy of induction chemo-immunotherapy for resectable node-positive squamous cell carcinoma of the penis
This description comes directly from the study's public registry record.
Michiel S. van der Heijden, PhD · +31205129111 · ms.vd.heijden@nki.nl
Jan-Jaap J. Mellema, MD · +31205129111 · j.mellema@nki.nl
Always discuss trial participation with your own doctor first.
| UZ Leuven | Leuven, Belgium | Recruiting |
| NKI-AVL | Amsterdam, North Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06353906